ArticleCancer medicine2025

Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.

Atsushi Naganuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.